Production and purification of recombinant fragment of pneumococcal surface protein A (PspA) in Escherichia coli

[1]  U. K. Laemmli,et al.  A factor preventing the major head protein of bacteriophage T4 from random aggregation. , 1970, Journal of molecular biology.

[2]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  M. Turner,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. , 1982, American journal of epidemiology.

[4]  B. Hovelius,et al.  A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres. , 1984, Acta oto-laryngologica.

[5]  J. C. Parke,et al.  Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates , 1986, Infection and immunity.

[6]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[7]  J. P. Li,et al.  Virulence, immunity, and vaccine related to Streptococcus pneumoniae. , 1991, Critical reviews in microbiology.

[8]  B. Plikaytis,et al.  Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. , 1991, The Journal of infectious diseases.

[9]  R. Tolman,et al.  Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex , 1992, Infection and immunity.

[10]  G. Siber.  Pneumococcal disease: prospects for a new generation of vaccines. , 1994, Science.

[11]  L. McDaniel,et al.  Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. , 1994, Microbial pathogenesis.

[12]  U. Rinas,et al.  Comparison of temperature- and isopropyl-β-d-thiogalacto-pyranoside-induced synthesis of basic fibroblast growth factor in high-cell-density cultures of recombinant Escherichia coli , 1995 .

[13]  J. Henrichsen,et al.  Six newly recognized types of Streptococcus pneumoniae , 1995, Journal of clinical microbiology.

[14]  D. Briles,et al.  Diversity of PspA: Mosaic Genes and Evidence for Past Recombination in Streptococcus pneumoniae , 2000, Infection and Immunity.

[15]  M. Brandileone,et al.  Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. , 2003, The Journal of infectious diseases.

[16]  Joseph Shiloach,et al.  Growing E. coli to high cell density--a historical perspective on method development. , 2005, Biotechnology advances.

[17]  T. C. Briles,et al.  Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae. , 2006, Microbial pathogenesis.

[18]  S. S. Tai.  Streptococcus pneumoniae Protein Vaccine Candidates: Properties, Activities and Animal Studies , 2006, Critical reviews in microbiology.

[19]  X. Geng,et al.  Liquid chromatography of recombinant proteins and protein drugs. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  J A Asenjo,et al.  Protein purification using chromatography: selection of type, modelling and optimization of operating conditions , 2009, Journal of molecular recognition : JMR.